Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
about
Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patientsTumor evolution and intratumor heterogeneity in colorectal carcinoma: insights from comparative genomic profiling of primary tumors and matched metastasesAssessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer.DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancerDifferentially regulated genes as putative targets of amplifications at 20q in ovarian cancersMelanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.Power to detect selective allelic amplification in genome-wide scans of tumor data.The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.Specific genomic aberrations in primary colorectal cancer are associated with liver metastasesAmplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer.RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.Calling amplified haplotypes in next generation tumor sequence data.Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer.Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.Genetics, cytogenetics, and epigenetics of colorectal cancer.Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancerChromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancerDeletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic responseGenomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study.Copy number alterations and allelic ratio in relation to recurrence of rectal cancerThe genetics of cancer susceptibility: from mouse to man.Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.Functionally-focused algorithmic analysis of high resolution microarray-CGH genomic landscapes demonstrates comparable genomic copy number aberrations in MSI and MSS sporadic colorectal cancer.Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.Impact of chromosome 17q deletion in the primary lesion of colorectal cancer on liver metastasis.Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation.Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.Chromosome 20q amplification regulates in vitro response to Kinesin-5 inhibitor.No SMAD4 hypermethylation in colorectal cancer.Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathwayGene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.Genetic profiling of colorectal cancer liver metastases by combined comparative genomic hybridization and G-banding analysis.Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis.Frequent allelic imbalance on chromosome 18q21 in early superficial colorectal cancers.A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patientsGenetic profiling of stage I and II colorectal cancer may predict metastatic relapse
P2860
Q24801499-1757D619-C23B-4207-AB8E-9C8E4970C992Q26772274-F8F68FFF-5BE3-4B09-8126-D6B806DB1D76Q27852685-0F9A68A3-8000-468F-B974-EE0855579E10Q28210483-54DC5CBC-F5A9-4CB7-B540-C99615E653C3Q28213364-7E822A09-565F-4A42-920D-11CCAE38D7C0Q30894063-12E6F8DE-A137-42B7-B077-105255946B2BQ33208475-57D5DA71-0A6B-47C0-A01A-666906185090Q33281073-5E4B7F6E-1486-4BA4-BA1A-66ED4715F87AQ33520624-371CFD1D-BA87-4664-A438-5537EF27D44BQ33673961-0F73F6CA-D52D-4E57-B5BC-7702628C781DQ33741891-0F12096E-E0CC-476B-9931-4B93046D62C8Q33761768-547D45C5-26AA-44B7-AA8D-A9F4EDAD3C28Q33812864-C23BDA3E-B685-41A2-90EE-57502DB453B5Q33913969-BA547151-D1BE-47E8-83B1-F9BF2A17D372Q34076335-BE871B56-3A3F-4BF2-9475-A2BDEB4DB58CQ34358357-FCE3532C-0BAB-4379-A472-D736E58B10CFQ34663849-7CEF85C3-3819-465E-9076-2909A390EBB8Q34758641-0E663F45-8364-4ED4-B5A3-F525B868BBEBQ34787876-B9CC4CDA-9F81-4BA3-A77F-7D8B54A37F81Q35100017-943C3637-B9A4-4BD7-8BDF-349AC84ED102Q35188897-7E243113-E270-4C13-9B93-D876FFCBC3F8Q35607847-60D3B937-E0AA-47AF-B017-978189F583EEQ35655094-D29ECC2B-A3C9-436E-A1E6-E2A81A2DFE8BQ35812486-0C44642A-F525-40F8-AE3E-F1554D379293Q35842194-2737AEB4-3817-4326-8BDA-71FA4E5538E0Q36288636-1DBB16F5-75A8-47FD-988C-78FC809EC90BQ37373790-9BD78EB4-25AE-4D74-9137-AC897F61F614Q37581942-87077F31-18B1-46EF-8303-A2E534DDAE4AQ38053346-F7BB5CEB-A69B-477B-810D-E69ECB50D556Q38916424-869CC6C8-FE0A-4C9F-A817-699965238278Q39505445-4515161E-8AFF-46BA-A666-7EEA28D5250AQ41914377-72BF0379-8654-4B51-9856-C3E399CCFC19Q42279596-518C0F5B-6087-47B8-94D5-61C2FA8BE9EDQ42857003-C426AEE2-71DB-4BF3-8FCE-C4519C6987C2Q53370638-3E5CA854-2BA0-43FD-865B-9ED5BBC11234Q53384068-34606235-261E-4D4C-B1C6-407B11D93C9AQ54656884-04553C62-B597-4F21-B651-62407637DA20Q55191845-65E175DF-E179-42A7-B8FE-EDFC12616DDBQ57185339-92310727-1ADE-4032-834E-27ABA2E4ED88Q57729114-47624F60-2598-4AFB-B236-C3D0419549FC
P2860
Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Chromosome arm 20q gains and o ...... escence in situ hybridization.
@en
type
label
Chromosome arm 20q gains and o ...... escence in situ hybridization.
@en
prefLabel
Chromosome arm 20q gains and o ...... escence in situ hybridization.
@en
P2093
P2860
P1476
Chromosome arm 20q gains and o ...... escence in situ hybridization.
@en
P2093
Waldman FM
Yasutake T
P2860
P356
10.1002/(SICI)1098-2264(199906)25:2<82::AID-GCC2>3.0.CO;2-6
P577
1999-06-01T00:00:00Z